Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF (1988) Abnormal
sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem
263:9310–9315
Miranda PS, Bosma PJ (2009) Towards liver-directed gene therapy for crigler-najjar syndrome.
Curr Gene Ther 9:72–82
Mise M, Hashizume T, Matsumoto S, Terauchi Y, Fujii T (2004a) Identification of non-functional
allelic variant ofCYP1A2in dogs. Pharmacogenetics 14:769–773
Mise M, Yadera S, Matsuda M, Hashizume T, Matsumoto S, Terauchi Y, Fujii T (2004b)
Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a
novel benzodiazepine receptor partial inverse agonist in dogs. Drug Metab Dispos 32:240–245
Mise M, Hashizume T, Komuro S (2008) Characterization of substrate specificity of dog CYP1A2
using CYP1A2-deficient and wild-type dog liver microsomes. Drug Metab Dispos
36:1903–1908
Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC
(2004) Breed distribution and history of canine mdr1–1D, a pharmacogenetic mutation that
marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci USA 101:
11725–11730
Nelson TE (1991) Malignant hyperthermia in dogs. J Am Vet Med Assoc 198:989–994
Nieto JE, Aleman M (2009) A rapid detection method for the ryanodine receptor 1 (C7360G)
mutation in quarter horses. J Vet Intern Med March 6th Epub ahead of print
O’Brien PJ, Cribb PH, White RJ, Olfert ED, Steiss JE (1983) Canine malignant hyperthermia:
diagnosis of susceptibility in a breeding colony. Can Vet J 24:172–177
O’Brien PJ, Pook HA, Klip A, Britt BA, Kalow BI, McLaughlin RN, Scott E, Elliott ME (1990)
Canine stress syndrome/malignant hyperthermia susceptibility: calcium-homeostasis defect in
muscle and lymphocytes. Res Vet Sci 48:124–128
Olse ́n L, Ingvast-Larsson C, Brostro ̈m H, Larsson P, Tja ̈lve H (2007) Clinical signs and etiology of
adverse reactions to procaine benzylpenicillin and sodium/potassium benzylpenicillin in
horses. J Vet Pharmacol Ther 30:201–207
Onoue M, Kurita A, Kado S, Matsumoto T, Kaneda N, Uchida K, Kato I, Yokokura T (2008)
Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset
diarrhea in rats. Cancer Chemother Pharmacol 61:595–605
Otterness DM, Weinshilboum RM (1987a) Mouse thiopurine methyltransferase pharmacogenetics:
Biochemical studies and recombinant inbred strains. J Pharmacol Exp Ther 243:180–186
Otterness DM, Weinshilboum RM (1987b) Mouse thiopurine methyltransferase pharmaco-
genetics: monogenic inheritance. J Pharmacol Exp Ther 240:817–824
Paul AJ, Tranquilli WJ, Seward RL, Todd KS Jr, DiPietro JA (1987) Clinical observations in
collies given ivermectin orally. Am J Vet Res 48:684–685
Paulson SK, Engel L, Reitz B, Bolten S, Burton EG, Maziasz TJ, Yan B, Schoenhard GL (1999)
Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor,
celecoxib. Drug Metab Dispos 27:1133–1142
Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P, Oude
Elferink RP (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-
associated protein gene. Science 271:1126–1128
Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ, Tytgat GN, Borst P, Baas F,
Oude Elferink RP (1997) A mutation in the human canalicular multispecific organic anion
transporter gene causes the Dubin-Johnson syndrome. Hepatology 25:1539–1542
Pelz HJ, Rost S, Hunerberg M, Fregin A, Heiberg AC, Baert K, MacNicoll AD, Prescott CV,
Walker AS, Oldenburg J, Muller CR (2005) The genetic basis of resistance to anticoagulants
in rodents. Genetics 170:1839–1847
Pippert TR, Umbenhauer DR (2001) The subpopulation of CF-1 mice deficient in P-glycoprotein
contains a murine retroviral insertion in the mdr1a gene. J Biochem Mol Toxicol 15:83–89
Pohjanvirta R, Viluksela M, Tuomisto JT, Unkila M, Karasinska J, Franc M-A, Holowenko M,
Giannone JV, Harper PA, Tuomisto J, Okey AB (1999) Physicochemical differences in the AH
74 C.M. Mosher and M.H. Court